AN2 Therapeutics (NASDAQ:ANTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does AN2 Therapeutics (ANTX) operate in?

AN2 Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

AN2 Therapeutics Stock (NASDAQ: ANTX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	1.81K / 455.17K
Day Range	- - -
52 Wk Range	0.87 - 22.22
Market Cap	$38.84M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	76
Short Interest	0.69%
Days to Cover	1

Recent News

Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

AN2 Therapeutics Plunges 66% in a Month: Here's Why

AN2 Therapeutics (NASDAQ: ANTX), a clinical-stage company, leverages its boron chemistry platform to develop novel small molecule therapeutics to potentially treat various infectious diseases and cancer indications.

Zacks

Citizens And 2 Other Penny Stocks Insiders Are Buying

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	1.81K / 455.17K
Day Range	- - -
52 Wk Range	0.87 - 22.22
Market Cap	$38.84M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	76
Short Interest	0.69%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy AN2 Therapeutics (ANTX) stock?

You can purchase shares of AN2 Therapeutics (NASDAQ:ANTX) through any online brokerage.

View our list of the best stock brokerages

Who are AN2 Therapeutics (ANTX) competitors?

Other companies in AN2 Therapeutics’s space includes: Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Lipocine (NASDAQ:LPCN) and Rani Therapeutics Hldgs (NASDAQ:RANI).

What is the forecast, or price target, for AN2 Therapeutics (ANTX) stock?

AN2 Therapeutics has a consensus price target of $13.50.

What is the current price for AN2 Therapeutics (ANTX)?

The stock price for AN2 Therapeutics (NASDAQ: ANTX) is $1.3 last updated November 21, 2024 at 4:57 AM EST.

Does AN2 Therapeutics (ANTX) pay a dividend?

A quarterly cash dividend of 0.66 per share of Class A Common Stock. The quarterly cash dividend was payable on February 1, 2018 to stockholders of record on January 11, 2018.

When is AN2 Therapeutics (NASDAQ:ANTX) reporting earnings?

AN2 Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is AN2 Therapeutics (ANTX) going to split?

There is no upcoming split for AN2 Therapeutics.

What sector and industry does AN2 Therapeutics (ANTX) operate in?

AN2 Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

AN2 Therapeutics

AN2 Therapeutics (ANTX) Forecast